These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 4149412)
61. An immunologic approach to the understanding of the physiologic disposition. Weiner M Life Sci; 1973 Dec; 13(11):1473-81. PubMed ID: 4129292 [No Abstract] [Full Text] [Related]
62. [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man]. Gachályi B; Tornyossy M; Vas A; Káldor A Orv Hetil; 1979 Apr; 120(15):897-8. PubMed ID: 372883 [No Abstract] [Full Text] [Related]
63. Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage. Sotaniemi EA; Hokkanen OT; Ahokas JT; Pelkonen RO; Ahlqvist J Eur J Clin Pharmacol; 1977 Dec; 12(6):429-35. PubMed ID: 598417 [No Abstract] [Full Text] [Related]
65. [Pharmacokinetics of preparations of lipoic acid and their effect on ATP synthesis, processes of microsomal and cytosol oxidation in hepatocytes in liver damage in man]. Loginov AS; Nilova TV; Bendikov EA; Petrakov AV Farmakol Toksikol; 1989; 52(4):78-82. PubMed ID: 2509239 [TBL] [Abstract][Full Text] [Related]
66. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man. Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879 [TBL] [Abstract][Full Text] [Related]
67. Interindividual differences in the metabolism of xenobiotics. Conney AH; Kappas A Carcinog Compr Surv; 1985; 10():147-66. PubMed ID: 3933828 [TBL] [Abstract][Full Text] [Related]
68. Inhibition of hepatic oxidative xenobiotic metabolism by piperonyl butoxide. Franklin MR Biochem Pharmacol; 1972 Dec; 21(24):3287-99. PubMed ID: 4405369 [No Abstract] [Full Text] [Related]
69. Editorial: Drug metabolism in disease. Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718 [No Abstract] [Full Text] [Related]
70. Overview of drug-protein binding. Gillette JR Ann N Y Acad Sci; 1973 Nov; 226():6-17. PubMed ID: 4588445 [No Abstract] [Full Text] [Related]
71. Interaction of environmental agents and drugs. Burns JJ Environ Res; 1969 Oct; 2(5):352-9. PubMed ID: 4985962 [No Abstract] [Full Text] [Related]
72. Abnormal drug metabolism following barbiturate and paracetamol overdosage. Forrest AH; Roscoe P; Stevenson IH; Prescott LF Scott Med J; 1974 May; 19(3):157. PubMed ID: 4829646 [No Abstract] [Full Text] [Related]
73. Histological changes in the liver and indices of drug metabolism in alcoholics. Sotaniemi EA; Ahlqvist J; Pelkonen RO; Pirttiaho H; Luoma PV Eur J Clin Pharmacol; 1977 Apr; 11(4):295-303. PubMed ID: 862651 [No Abstract] [Full Text] [Related]
75. [Pharmacokinetics in liver cirrhosis]. Ackermann E Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389 [TBL] [Abstract][Full Text] [Related]
76. Keynote address: man, mice, microsomes, metabolites, and mathematics 40 years after the revolution. Gillette JR Drug Metab Rev; 1995; 27(1-2):1-44. PubMed ID: 7641571 [No Abstract] [Full Text] [Related]
77. Aging and drug disposition: an update. Schmucker DL Pharmacol Rev; 1985 Jun; 37(2):133-48. PubMed ID: 3901045 [No Abstract] [Full Text] [Related]
78. Cancer and nutrition (review). McLean AE Nahrung; 1976; 20(4):339-42. PubMed ID: 781541 [No Abstract] [Full Text] [Related]
79. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure. Van Peer AP; Belpaire FM; Rosseel MT; Bogaert MG Pharmacology; 1981; 22(2):139-45. PubMed ID: 7208595 [TBL] [Abstract][Full Text] [Related]
80. Enzyme induction and medical treatment. Hunter J J R Coll Physicians Lond; 1974 Jan; 8(2):163-74. PubMed ID: 4810112 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]